Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bern

Showing results (871-880 of 886) with videos related to

Pageof 89
Sort By:
Nature Communications|March 7, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteriaStian Foss, Siri A Sakya, Leire Aguinagalde, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Space Science Reviews|November 21, 2022
Science of the Van Allen Probes Science Operations CentersJerry W Manweiler, Aaron Breneman, Jonathan Niehof, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
Frontiers in Cellular and Infection Microbiology|April 12, 2021
Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in IndiaPushkar Dubey, Aritra Das, Khushbu Priyamvada, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2026
A comparison of F/TAF and F/TDF as HIV pre-exposure prophylaxis in a predominantly cisgender women population in East and South Africa: a randomised, factorial, non-inferiority trialSheena McCormack, David Dunn, Sylvia Kusemererwa, et al.
Pageof 89

Showing results (871-880 of 886) with videos related to

Sort By:
Pageof 89
Nature Communications|March 7, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteriaStian Foss, Siri A Sakya, Leire Aguinagalde, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Space Science Reviews|November 21, 2022
Science of the Van Allen Probes Science Operations CentersJerry W Manweiler, Aaron Breneman, Jonathan Niehof, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Nature Communications|May 1, 2025
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse modelsAina Karen Anthi, Anette Kolderup, Eline Benno Vaage, et al.
Frontiers in Cellular and Infection Microbiology|April 12, 2021
Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in IndiaPushkar Dubey, Aritra Das, Khushbu Priyamvada, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2026
A comparison of F/TAF and F/TDF as HIV pre-exposure prophylaxis in a predominantly cisgender women population in East and South Africa: a randomised, factorial, non-inferiority trialSheena McCormack, David Dunn, Sylvia Kusemererwa, et al.
Pageof 89